Community program helps lower blood pressure among minorities

American Heart Association meeting report abstract 200

2014-06-03

(Press-News.org) Minorities at a higher risk of developing hypertension used a community-based program to significantly lower their blood pressure, researchers said at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.

Minorities at a higher risk of developing hypertension used a community-based program to significantly lower their blood pressure, researchers said at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.

Researchers assessed the use of the American Heart Association's Check. Change. Control. program in 18 urban, predominately African-American communities with a high rate of high blood pressure.

The 4,069 participants used the program over four months in 2013 in churches, workplace wellness facilities, healthcare centers and housing centers.

Researchers found that those who checked their blood pressure more frequently had the largest drop in blood pressure. The programs that included blood pressure monitoring kits, blood pressure checks during activities like walking clubs and cooking classes and volunteers who led activities had the best results.

"This program capitalizes on local resources that can bring about change in behavior and improve blood pressure rates," said Monique Anderson, M.D., lead researcher of the study and a medical instructor in cardiology at the Duke Clinical Research Institute and the Duke School of Medicine in Durham, N.C. "As participants became more knowledgeable, they probably started exercising more, taking their medication more, and those who were really engaged showed dramatic responses in blood pressure change."

They also found: Among all participants, systolic pressure dropped 7.5 mmHg and diastolic dropped 3.3 mmHg during the study period. When participants entered at least eight of their readings, the reduction was even greater: 13.9 mmHg in systolic and 5.0 mmHg in diastolic. The largest average reduction at one site was 29.8 mmHg (systolic) and 9.9 mmHg (diastolic).

While each community could design some elements of their program, they had certain factors in common that are easy to replicate and implement: All participants were encouraged to upload their blood pressure readings to http://www.heart360.org for tracking. American Heart Association staff led the programs and partnered with businesses and others such as senior residential institutions. Programs with the highest engagement were more likely to hold hypertension education classes and follow up with participants via telephone or face-to-face contact.

About 78 million people in the United States have high blood pressure. It's called the silent killer because it typically has no symptoms. Some populations, including African-Americans, have higher risks of developing high blood pressure.

"Check. Change. Control. is remarkable because of its size and scope and its impact on public health," said Eric Peterson, M.D., M.P.H., principal investigator. "But rather than just being satisfied with success, we're trying to understand which parts of the program were most effective so we can improve it as it is expanded to the rest of the nation."

INFORMATION: Co-authors are Emily O'Brien, Ph.D.; Nancy Allen-Lapointe, Pharm. D.; Rachel Peragallo Urrutia, M.D., M.Sc.; Angel M. Alexander, M.S.P.H.; Alexander J. Christian, B.S.P.H.; Lisa McCoy, M.S.; Juliana Crawford, Ba.Sc.; Laura M. Webb, B.S.; Paramita Saha Chaudhuri, Ph.D.; Patrick Wayte, MBA; Eric D. Peterson, M.D., M.P.H. Author disclosures are on the abstract.

The American Heart Association and Duke Clinical Research Institute funded the study.

Additional Resources: Heart360.org Assess Your High Blood Pressure Related Risks Reseacher and blood pressure photos are available on the right column of this news release link http://newsroom.heart.org/news/community-program-helps-lower-blood-pressure-among-minorities?preview=fd151b5c15c25a578d90dadb9a3dc233 Follow AHA/ASA news on Twitter @HeartNews #QCOR14.

NOTE: Presentation is 3:00 p.m. CT/4:00 p.m. ET Tuesday, June 3, 2014.

Statements and conclusions of study authors presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

For Media Inquiries: (214) 706-1173

Michael Burton: (214) 706-1236; michael.burton@heart.org

Cathy Lewis: (214) 706-1324; cathy.lewis@heart.org

Julie Del Barto (broadcast): (214) 706-1330; julie.delbarto@heart.org

For Public Inquiries: (800) AHA-USA1 (242-8721)

http://www.heart.org and http://www.strokeassociation.org

ELSE PRESS RELEASES FROM THIS DATE:

Implanted heart device linked to increased survival

2014-06-03

DURHAM, N.C. -- Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute. The findings, published in the June 4 issue of the Journal of the American Medical Association, support existing recommendations to implant ICDs in patients with a left ventricular ejection fraction (LVEF) – a measurement of how much blood is squeezed out of the heart – of 35 percent ...

High risk of recurrence of 2 life-threatening adverse drug reactions

2014-06-03

Individuals who are hospitalized for the skin conditions of Stevens-Johnson syndrome and toxic epidermal necrolysis appear to have a high risk of recurrence, according to a study in the June 4 issue of JAMA. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening conditions that develop primarily as responses to drugs, and result in extensive epidermal detachment (upper layers of the skin detach from the lower layers). Recurrence has been reported in isolated cases, and the overall risk of recurrence has been unknown, according to background ...

Outcomes for older adults with pneumonia who receive treatment including azithromycin

2014-06-03

In a study that included nearly 65,000 older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a significantly lower risk of death and a slightly increased risk of heart attack, according to a study in the June 4 issue of JAMA. Pneumonia and influenza together are the eighth leading cause of death and the leading causes of infectious death in the United States. Although clinical practice guidelines recommend combination therapy with macrolides (a class of antibiotics), including azithromycin, ...

Preventive placement of ICDs for less severe heart failure may improve survival

2014-06-03

An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA. Although clinical trials have established the ICD as the best currently available therapy to prevent sudden cardiac death in patients with heart failure, some uncertainties remain regarding preventive use of ICDs in patients ...

Study: New test predicts if breast cancer will spread

2014-06-03

June 3, 2014 – BRONX, NY – The study was led by researchers at the National Cancer Institute (NCI)─designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein Center for Cancer Care and was published online today in the Journal of the National Cancer Institute (JNCI). "Tests assessing metastatic risk can help doctors identify which patients should receive aggressive therapy and which patients should be spared," said Thomas Rohan, M.D., Ph.D., the lead and corresponding author of the study and professor ...

Deeper than ancestry.com, 'EvoCor' identifies gene relationships

2014-06-03

A frontier lies deep within our cells. Our bodies are as vast as oceans and space, composed of a dizzying number of different types of cells. Exploration reaches far, yet the genes that make each cell and tissue unique have remained largely obscure. That's changing with the help of a team led by Gregorio Valdez, an assistant professor at the Virginia Tech Carilion Research Institute. Valdez and his team designed a search engine – called EvoCor – that identifies genes that are functionally linked. The name, a portmanteau of "evolution" and "correlation," points to ...

New definition of kidney disease for clinical trials could lead to new treatments

2014-06-03

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that new therapies for kidney disease could be developed more quickly by revising the definition of kidney disease progression used during clinical trials. If adopted, the new definition could shorten the length of some clinical trials and also potentially encourage more clinical trials in kidney disease. The findings will be published in the June 3, 2014 online edition of the Journal of the American Medical Association. Chronic kidney disease (CKD) is a worldwide public health ...

2-D transistors promise a faster electronics future

2014-06-03

Faster electronic device architectures are in the offing with the unveiling of the world's first fully two-dimensional field-effect transistor (FET) by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab). Unlike conventional FETs made from silicon, these 2D FETs suffer no performance drop-off under high voltages and provide high electron mobility, even when scaled to a monolayer in thickness. Ali Javey, a faculty scientist in Berkeley Lab's Materials Sciences Division and a UC Berkeley professor of electrical engineering and computer science, led ...

Investigating unusual three-ribbon solar flares with extreme high resolution

2014-06-03

The 1.6 meter telescope at Big Bear Solar Observatory (BBSO) in California has given researchers unparalleled capability for investigating phenomena such as solar flares. Operated by New Jersey Institute of Technology (NJIT), the BBSO instrument is the most powerful ground-based telescope dedicated to studying the star closest to Earth. On June 2, Distinguished Professor of Physics Haimin Wang joined NJIT colleagues at the 224th meeting of the American Astronomical Society (AAS), held in Boston, Massachusetts, to present intriguing data about solar flares — specifically, ...

Solving sunspot mysteries

2014-06-03

Multi-wavelength observations of sunspots with the 1.6-meter telescope at Big Bear Solar Observatory (BBSO) in California and aboard NASA's IRIS spacecraft have produced new and intriguing images of high-speed plasma flows and eruptions extending from the Sun's surface to the outermost layer of the solar atmosphere, the corona. Operated by New Jersey Institute of Technology (NJIT), BBSO houses the largest ground-based telescope dedicated to solar research. On June 2, NJIT researchers reported on the acquisition of these images at the 224th meeting of the American Astronomical ...

LAST 30 PRESS RELEASES:

The threat of polio paralysis may have disappeared, but enterovirus paralysis is just as dangerous and surveillance and testing systems are desperately needed

Study shows ChatGPT failed when challenging ESCMID guideline for treating brain abscesses

Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds